EYPT EyePoint, Inc.

NASDAQ
$4.23

EyePoint, Inc. (EYPT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with EYPT's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 1 seller in the last 90 days
Insiders buying
2
2 transactions
Insiders selling
3
11 transactions
Purchases
$72.0K
12,100 shares
Sales
$2.0M
127,453 shares
Net activity
-$2.0M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $2.0M 11 transactions · 127,453 shares

Largest single sale: $942.2K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 18, 2026 , by Zaderej Karen L. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Zaderej Karen L. Director Buy 10,600 $4.93 $52.3K 49,100
Ribeiro Ramiro 2 fills Chief Medical Officer Sell 4,875 $15.01 $73.2K 2,438 −66.7% of holding
Ribeiro Ramiro Chief Medical Officer Sell 2,437 $15.00 $36.6K None left
Duker Jay S. President and CEO Buy 1,500 $13.15 $19.7K 100,665
Ribeiro Ramiro Chief Medical Officer Sell 2,438 $17.87 $43.6K None left
Ribeiro Ramiro Chief Medical Officer Sell 2,437 $15.00 $36.6K None left
Ribeiro Ramiro Chief Medical Officer Sell 42,544 $17.10 $727.3K None left
Sell 60,000 $15.70 $942.2K 8,265,000 −0.7% of holding
Lurker Nancy Director Sell 9,300 $15.11 $140.5K 206,547 −4.3% of holding
Lurker Nancy Director Sell 500 $14.95 $7.5K 215,847 −0.2% of holding
Lurker Nancy Director Sell 200 $14.95 $3.0K 216,347 −0.1% of holding
Ribeiro Ramiro Chief Medical Officer Sell 2,722 $11.61 $31.6K None left

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.